82 results
8-K
EX-10.1
DRRX
Durect Corp
21 Jul 23
DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
5:13pm
and shall expire when exercised in full, in the form of Exhibit A-2 attached hereto.
“Proceeding” means an action, claim, suit, investigation … or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened
8-K
EX-10.1
DRRX
Durect Corp
5 Jul 22
DURECT Corporation Appoints Timothy M. Papp as Chief Financial Officer
9:01am
investigation and pre-employment drug screening test due to the fact that DURECT is engaged in the development and manufacture of pharmaceutical products … , including controlled substances. Your representing agency, Spencer Stuart, will conduct your background investigation. As for your pre-employment drug
8-K
EX-1.1
v3kjpw1k
5 Feb 21
DURECT Corporation Announces Pricing of $42.5 Million Public Offering of Common Stock
4:48pm
8-K
EX-10.1
x4z8roubbf143dt
2 Nov 20
DURECT Corporation Appoints Dr. Norman Sussman as Chief Medical Officer
4:16pm
S-8
jy4s z1lvftdy8cn
4 Aug 20
Registration of securities for employees
1:25pm
8-K
EX-99.1
wed42s3m4
9 Sep 19
Other Events
1:36pm
8-K
EX-10.1
t2u4wz6818cxd
20 Jun 19
DURECT Announces $15 Million Registered Direct Offering
9:00am
8-K
EX-99.1
536f0kvxfktyej
3 May 19
Other Events
5:24pm